Previously unpublished trial data explain effects and side effects of key MS drug
Alemtuzumab is a highly effective drug for multiple sclerosis, approved in more than 60 countries and used by more than 12,000 patients worldwide. However, there is an almost 50 per cent risk of secondary autoimmune diseases, ...
Jun 12, 2017
0
0